NASDAQ:NMRA | Profit Breakdown | Neumora Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2022-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$42.19M-$43.08M-$43.08M
2026-03-31-$52.86M-$53.43M-$53.46M
2025-12-31-$58.48M-$59.45M-$59.45M
2025-09-30-$57.7M-$56.76M-$56.76M
2025-06-30-$54.04M-$52.71M-$52.73M
2025-03-31-$70.94M-$67.89M-$67.99M
2024-12-31-$62.92M-$58.82M-$58.82M
2024-09-30-$76.65M-$72.49M-$72.55M
2024-06-30-$63.82M-$58.58M-$58.7M
2024-03-31-$60.07M-$53.72M-$53.72M
2023-12-31-$114M-$108.46M-$108.73M
2023-09-30-$56.86M-$53.03M-$53.03M
2023-06-30-$42.06M-$38.54M-$38.54M
2023-03-31-$39.17M-$35.63M
2022-12-31-$30.72M-$28.15M
2022-09-30-$30.6M-$29.34M
2022-06-30-$30.37M
2022-03-31-$43.04M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$241.16M-$236.8M-$236.93M
2024-12-31-$263.46M-$243.61M-$243.79M
2023-12-31-$252.1M-$235.66M-$235.93M
2022-12-31-$135.87M-$130.9M-$130.9M